273 related articles for article (PubMed ID: 12805103)
1. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice.
Wells JE; Hurlbert RJ; Fehlings MG; Yong VW
Brain; 2003 Jul; 126(Pt 7):1628-37. PubMed ID: 12805103
[TBL] [Abstract][Full Text] [Related]
2. Minocycline treatment inhibits lipid peroxidation, preserves spinal cord ultrastructure, and improves functional outcome after traumatic spinal cord injury in the rat.
Sonmez E; Kabatas S; Ozen O; Karabay G; Turkoglu S; Ogus E; Yilmaz C; Caner H; Altinors N
Spine (Phila Pa 1976); 2013 Jul; 38(15):1253-9. PubMed ID: 23370685
[TBL] [Abstract][Full Text] [Related]
3. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat.
Lee SM; Yune TY; Kim SJ; Park DW; Lee YK; Kim YC; Oh YJ; Markelonis GJ; Oh TH
J Neurotrauma; 2003 Oct; 20(10):1017-27. PubMed ID: 14588118
[TBL] [Abstract][Full Text] [Related]
4. Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury.
Lee JH; Tigchelaar S; Liu J; Stammers AM; Streijger F; Tetzlaff W; Kwon BK
Exp Neurol; 2010 Sep; 225(1):219-30. PubMed ID: 20599974
[TBL] [Abstract][Full Text] [Related]
5. A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model.
Pinzon A; Marcillo A; Quintana A; Stamler S; Bunge MB; Bramlett HM; Dietrich WD
Brain Res; 2008 Dec; 1243():146-51. PubMed ID: 18838063
[TBL] [Abstract][Full Text] [Related]
6. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury.
Stirling DP; Khodarahmi K; Liu J; McPhail LT; McBride CB; Steeves JD; Ramer MS; Tetzlaff W
J Neurosci; 2004 Mar; 24(9):2182-90. PubMed ID: 14999069
[TBL] [Abstract][Full Text] [Related]
7. Administration of low dose estrogen attenuates persistent inflammation, promotes angiogenesis, and improves locomotor function following chronic spinal cord injury in rats.
Samantaray S; Das A; Matzelle DC; Yu SP; Wei L; Varma A; Ray SK; Banik NL
J Neurochem; 2016 May; 137(4):604-17. PubMed ID: 26998684
[TBL] [Abstract][Full Text] [Related]
8. Beyond the lesion site: minocycline augments inflammation and anxiety-like behavior following SCI in rats through action on the gut microbiota.
Schmidt EKA; Raposo PJF; Torres-Espin A; Fenrich KK; Fouad K
J Neuroinflammation; 2021 Jun; 18(1):144. PubMed ID: 34174901
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of minocycline and FK506 alone and in combination on enhanced behavioral and biochemical recovery from spinal cord injury in rats.
Ahmad M; Zakaria A; Almutairi KM
Pharmacol Biochem Behav; 2016 Jun; 145():45-54. PubMed ID: 27106204
[TBL] [Abstract][Full Text] [Related]
10. Low-energy extracorporeal shock wave therapy promotes vascular endothelial growth factor expression and improves locomotor recovery after spinal cord injury.
Yamaya S; Ozawa H; Kanno H; Kishimoto KN; Sekiguchi A; Tateda S; Yahata K; Ito K; Shimokawa H; Itoi E
J Neurosurg; 2014 Dec; 121(6):1514-25. PubMed ID: 25280090
[TBL] [Abstract][Full Text] [Related]
11. Minocycline Enhance the Restorative Ability of Olfactory Ensheathing Cells by the Upregulation of BDNF and GDNF Expression After Spinal Cord Injury.
Pourkhodadad S; Oryan S; Hadipour MM; Kaka G; Sadraie SH
Basic Clin Neurosci; 2021; 12(6):777-788. PubMed ID: 35693138
[TBL] [Abstract][Full Text] [Related]
12. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice.
Wells JE; Rice TK; Nuttall RK; Edwards DR; Zekki H; Rivest S; Yong VW
J Neurosci; 2003 Nov; 23(31):10107-15. PubMed ID: 14602826
[TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury.
Rabchevsky AG; Fugaccia I; Fletcher-Turner A; Blades DA; Mattson MP; Scheff SW
J Neurotrauma; 1999 Sep; 16(9):817-30. PubMed ID: 10521141
[TBL] [Abstract][Full Text] [Related]
14. Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury.
Pannu R; Christie DK; Barbosa E; Singh I; Singh AK
J Neurochem; 2007 Apr; 101(1):182-200. PubMed ID: 17217414
[TBL] [Abstract][Full Text] [Related]
15. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats.
Bethea JR; Nagashima H; Acosta MC; Briceno C; Gomez F; Marcillo AE; Loor K; Green J; Dietrich WD
J Neurotrauma; 1999 Oct; 16(10):851-63. PubMed ID: 10547095
[TBL] [Abstract][Full Text] [Related]
16. Two-photon-excited fluorescence microscopy as a tool to investigate the efficacy of methylprednisolone in a mouse spinal cord injury model.
Zhang Y; Zhang L; Shen J; Chen C; Mao Z; Li W; Gan WB; Tang P
Spine (Phila Pa 1976); 2014 Apr; 39(8):E493-9. PubMed ID: 24480947
[TBL] [Abstract][Full Text] [Related]
17. Free radical scavenger edaravone produces robust neuroprotection in a rat model of spinal cord injury.
Ishii H; Petrenko AB; Sasaki M; Satoh Y; Kamiya Y; Tobita T; Furutani K; Matsuhashi M; Kohno T; Baba H
Brain Res; 2018 Mar; 1682():24-35. PubMed ID: 29294349
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole.
Schwartz G; Fehlings MG
J Neurosurg; 2001 Apr; 94(2 Suppl):245-56. PubMed ID: 11302627
[TBL] [Abstract][Full Text] [Related]
19. A combination immunomodulatory treatment promotes neuroprotection and locomotor recovery after contusion SCI.
Iannotti CA; Clark M; Horn KP; van Rooijen N; Silver J; Steinmetz MP
Exp Neurol; 2011 Jul; 230(1):3-15. PubMed ID: 20338167
[TBL] [Abstract][Full Text] [Related]
20. Effects of combined treatment of minocycline and methylprednisolone on the expression of tumor necrosis factor alpha and interleukine-6 in experimental spinal cord injury: a light and electron microscopic study.
Sencar L; Yilmaz DM; Tuli A; Polat S
Ultrastruct Pathol; 2020 May; 44(3):283-299. PubMed ID: 32567988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
